12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Multikine: Phase III ongoing

Cel-Sci said an IDMC found no safety concerns in an open-label, international Phase III trial of Multikine based on a review of safety data. The trial is...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >